Literature DB >> 2999573

Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.

J Abb.   

Abstract

Sera from 32 homosexual men were studied for the presence of antibodies against human T-lymphotropic virus type III (HTLV III) and acid-labile interferon (IFN) alpha. Infection with HTLV III was found to be associated with the presence of serum IFN. IFN was detected in 74% of sera from male homosexuals with HTLV III antibody, but in only 6% of sera from antibody-negative individuals. More than 80% of sera from HTLV III-infected patients with the acquired immune deficiency syndrome (AIDS) or pre-AIDS conditions (generalized lymphadenopathy or the AIDS-related complex) were positive for IFN, while IFN was not present in sera from healthy homosexual men with HTLV III antibody. In conclusion, the presence of serum IFN may be predictive of the development of AIDS or pre-AIDS conditions in male homosexuals exposed to HTLV III.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999573     DOI: 10.1007/bf02123697

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  16 in total

1.  Is presence of interferon predictive for AIDS?

Authors:  E Buimovici-Klein; M Lange; R J Klein; L Z Cooper; M H Grieco
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

2.  Antibodies to HTLV-III in German blood donors.

Authors:  J Schneider; H Bayer; U Bienzle; P Wernet; G Hunsmann
Journal:  Lancet       Date:  1985-02-02       Impact factor: 79.321

3.  HTLV-III antibody status and immunological abnormalities in haemophilic patients.

Authors:  E H Moffat; A L Bloom; P P Mortimer
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

Review 4.  A pathogenic retrovirus (HTLV-III) linked to AIDS.

Authors:  S Broder; R C Gallo
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

5.  Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections.

Authors:  C Lopez; P A Fitzgerald; F P Siegal
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

6.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

Authors:  E DeStefano; R M Friedman; A E Friedman-Kien; J J Goedert; D Henriksen; O T Preble; J A Sonnabend; J Vilcek
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

7.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Interferon production in male homosexuals with the acquired immune deficiency syndrome (AIDS) or generalized lymphadenopathy.

Authors:  J Abb; M Kochen; F Deinhardt
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

View more
  3 in total

1.  Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells.

Authors:  M R Capobianchi; F De Marco; P Di Marco; F Dianzani
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures.

Authors:  J Szebeni; C Dieffenbach; S M Wahl; C N Venkateshan; A Yeh; M Popovic; S Gartner; L M Wahl; M Peterfy; R M Friedman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  HIV antigen, HIV antibody and serum interferon in a patient with encephalopathy.

Authors:  J Abb; R Zachoval; V Zachoval; F Deinhardt
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.